Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial

Panettieri Jr, R. A., Camargo Jr, C. A., Cheema, T., El Bayadi, S. G., Fiel, S., Vila, T. M., Jain, R. G., Midwinter, D., Thomashow, B., Ludwig-Sengpiel, A., & Lipson, D. A. (2022). Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial. International Journal of Chronic Obstructive Pulmonary Disease, Volume 17, 2043–2052. https://doi.org/10.2147/copd.s367701
Authors:
Reynold A. Panettieri
Carlos A. Camargo
Tariq Cheema
Sherif G El Bayadi
Stanley B. Fiel
Tania M Vila
Renu Jain
Dawn Midwinter
Byron Thomashow
Andrea Ludwig-Sengpiel
David A. Lipson
Affiliated Authors:
Byron Thomashow
Author Keywords:
copd
exacerbations
severe exacerbations
triple therapy
ics
laba
ics/laba
Publication Type:
Article
Unique ID:
10.2147/copd.s367701
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: